APO Research
Talk to an analyst

APO RESEARCH · REPORT

Equine Influenza Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Equine Influenza Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025177 pages

Choose your research edition.

Industry ResearchEquine Influenza Vaccine Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Equine Influenza Vaccine Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Equine Influenza Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Equine Influenza Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Equine Influenza Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Equine Influenza Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Equine Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Equine Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Equine Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Equine Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Equine Influenza Vaccine include Zoetis, Merck Animal Health and Boehringer Ingelheim Vetmedica, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Equine Influenza Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Equine Influenza Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Equine Influenza Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Equine Influenza Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Equine Influenza Vaccine Segment by Company

Zoetis

Merck Animal Health

Boehringer Ingelheim Vetmedica

Equine Influenza Vaccine Segment by Type

Liquid

Powder

Equine Influenza Vaccine Segment by Application

Home

Pet Clinic

Others

Equine Influenza Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equine Influenza Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Equine Influenza Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Equine Influenza Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Equine Influenza Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Equine Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Equine Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Equine Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Equine Influenza Vaccine Industry Trends Table 2. Equine Influenza Vaccine Industry Drivers Table 3. Equine Influenza Vaccine Industry Opportunities and Challenges Table 4. Equine Influenza Vaccine Industry Restraints Table 5. Global Equine Influenza Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Equine Influenza Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Equine Influenza Vaccine Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Equine Influenza Vaccine Sales Market Share by Manufacturers Table 9. Global Equine Influenza Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Equine Influenza Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Equine Influenza Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Equine Influenza Vaccine Manufacturers, Product Type & Application Table 13. Global Equine Influenza Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Equine Influenza Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Liquid Table 17. Major Manufacturers of Powder Table 18. Global Equine Influenza Vaccine Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 19. Global Equine Influenza Vaccine Sales by Type (2021-2026) & (W Units) Table 20. Global Equine Influenza Vaccine Sales by Type (2027-2032) & (W Units) Table 21. Global Equine Influenza Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Equine Influenza Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Equine Influenza Vaccine Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Equine Influenza Vaccine Revenue by Type (2021-2026) & (W Units) Table 25. Global Equine Influenza Vaccine Revenue by Type (2027-2032) & (W Units) Table 26. Global Equine Influenza Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Equine Influenza Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Home Table 29. Major Manufacturers of Pet Clinic Table 30. Major Manufacturers of Others Table 31. Global Equine Influenza Vaccine Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 32. Global Equine Influenza Vaccine Sales by Application (2021-2026) & (W Units) Table 33. Global Equine Influenza Vaccine Sales by Application (2027-2032) & (W Units) Table 34. Global Equine Influenza Vaccine Sales Market Share by Application (2021-2026) Table 35. Global Equine Influenza Vaccine Sales Market Share by Application (2027-2032) Table 36. Global Equine Influenza Vaccine Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global Equine Influenza Vaccine Revenue by Application (2021-2026) & (W Units) Table 38. Global Equine Influenza Vaccine Revenue by Application (2027-2032) & (W Units) Table 39. Global Equine Influenza Vaccine Revenue Market Share by Application (2021-2026) Table 40. Global Equine Influenza Vaccine Revenue Market Share by Application (2027-2032) Table 41. Global Equine Influenza Vaccine Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 42. Global Equine Influenza Vaccine Sales by Region (2021-2026) & (W Units) Table 43. Global Equine Influenza Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Equine Influenza Vaccine Sales Forecasted by Region (2027-2032) & (W Units) Table 45. Global Equine Influenza Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Equine Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 47. North America Equine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 48. North America Equine Influenza Vaccine Sales by Country (2027-2032) & (W Units) Table 49. Europe Equine Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 50. Europe Equine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 51. Europe Equine Influenza Vaccine Sales by Country (2027-2032) & (W Units) Table 52. Asia Pacific Equine Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 53. Asia Pacific Equine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 54. Asia Pacific Equine Influenza Vaccine Sales by Country (2027-2032) & (W Units) Table 55. South America, Middle East and Africa Equine Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. South America, Middle East and Africa Equine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 57. South America, Middle East and Africa Equine Influenza Vaccine Sales by Country (2027-2032) & (W Units) Table 58. Global Equine Influenza Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Equine Influenza Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Equine Influenza Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Equine Influenza Vaccine Revenue Market Share by Region (2021-2026) Table 62. Global Equine Influenza Vaccine Revenue Market Share by Region (2027-2032) Table 63. Zoetis Company Information Table 64. Zoetis Business Overview Table 65. Zoetis Equine Influenza Vaccine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Zoetis Equine Influenza Vaccine Product Portfolio Table 67. Zoetis Recent Development Table 68. Merck Animal Health Company Information Table 69. Merck Animal Health Business Overview Table 70. Merck Animal Health Equine Influenza Vaccine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Merck Animal Health Equine Influenza Vaccine Product Portfolio Table 72. Merck Animal Health Recent Development Table 73. Boehringer Ingelheim Vetmedica Company Information Table 74. Boehringer Ingelheim Vetmedica Business Overview Table 75. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Product Portfolio Table 77. Boehringer Ingelheim Vetmedica Recent Development Table 78. Key Raw Materials Table 79. Raw Materials Key Suppliers Table 80. Equine Influenza Vaccine Distributors List Table 81. Equine Influenza Vaccine Customers List Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. Equine Influenza Vaccine Product Image Figure 2. Global Equine Influenza Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Equine Influenza Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Equine Influenza Vaccine Sales (2021-2032) & (W Units) Figure 5. Global Equine Influenza Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Equine Influenza Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Liquid Image Figure 9. Powder Image Figure 10. Global Equine Influenza Vaccine Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 11. Global Equine Influenza Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Equine Influenza Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Equine Influenza Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Equine Influenza Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Equine Influenza Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Home Image Figure 17. Pet Clinic Image Figure 18. Others Image Figure 19. Global Equine Influenza Vaccine Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 20. Global Equine Influenza Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Equine Influenza Vaccine Sales Market Share by Application (2021-2032) Figure 22. Global Equine Influenza Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Equine Influenza Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Equine Influenza Vaccine Revenue Market Share by Application (2021-2032) Figure 25. North America Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 26. North America Equine Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 27. U.S. Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 28. Canada Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Mexico Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Europe Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Europe Equine Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 32. Germany Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 33. France Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 34. U.K. Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Italy Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Netherlands Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Asia Pacific Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Asia Pacific Equine Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 39. China Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Japan Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 41. South Korea Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Southeast Asia Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 43. India Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Australia Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 45. South America, Middle East and Africa Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South America, Middle East and Africa Equine Influenza Vaccine Sales Market Share by Country (2021-2032) Figure 47. Brazil Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South Africa Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Saudi Arabia Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Turkey Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Argentina Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 52. UAE Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Egypt Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Chile Equine Influenza Vaccine Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Global Equine Influenza Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Equine Influenza Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Equine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Figure 58. North America Equine Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Equine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Equine Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Equine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Equine Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Equine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Equine Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Equine Influenza Vaccine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Equine Influenza Vaccine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid
  • Powder
Applications
  • Home
  • Pet Clinic
  • Others
Companies covered
  • Zoetis
  • Merck Animal Health
  • Boehringer Ingelheim Vetmedica

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Equine Influenza Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Equine Influenza Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Equine Influenza Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Equine Influenza Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Equine Influenza Vaccine Market Dynamics
  1. 2.1 Equine Influenza Vaccine Industry Trends
  2. 2.2 Equine Influenza Vaccine Industry Drivers
  3. 2.3 Equine Influenza Vaccine Industry Opportunities and Challenges
  4. 2.4 Equine Influenza Vaccine Industry Restraints
3 Equine Influenza Vaccine Market by Manufacturers
  1. 3.1 Global Equine Influenza Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Equine Influenza Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Equine Influenza Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Equine Influenza Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Equine Influenza Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Equine Influenza Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Equine Influenza Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Equine Influenza Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Equine Influenza Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Equine Influenza Vaccine Tier 1, Tier 2, and Tier 3
4 Equine Influenza Vaccine Market by Type
  1. 4.1 Equine Influenza Vaccine Type Introduction
  2. 4.1.1 Liquid
  3. 4.1.2 Powder
  4. 4.2 Global Equine Influenza Vaccine Sales by Type
  5. 4.2.1 Global Equine Influenza Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Equine Influenza Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Equine Influenza Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Equine Influenza Vaccine Revenue by Type
  9. 4.3.1 Global Equine Influenza Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Equine Influenza Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Equine Influenza Vaccine Revenue Market Share by Type (2021-2032)
5 Equine Influenza Vaccine Market by Application
  1. 5.1 Equine Influenza Vaccine Application Introduction
  2. 5.1.1 Home
  3. 5.1.2 Pet Clinic
  4. 5.1.3 Others
  5. 5.2 Global Equine Influenza Vaccine Sales by Application
  6. 5.2.1 Global Equine Influenza Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Equine Influenza Vaccine Sales by Application (2021-2032)
  8. 5.2.3 Global Equine Influenza Vaccine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Equine Influenza Vaccine Revenue by Application
  10. 5.3.1 Global Equine Influenza Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Equine Influenza Vaccine Revenue by Application (2021-2032)
  12. 5.3.3 Global Equine Influenza Vaccine Revenue Market Share by Application (2021-2032)
6 Global Equine Influenza Vaccine Sales by Region
  1. 6.1 Global Equine Influenza Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Equine Influenza Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Equine Influenza Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Equine Influenza Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Equine Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Equine Influenza Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Equine Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Equine Influenza Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Equine Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Equine Influenza Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Equine Influenza Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Equine Influenza Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Equine Influenza Vaccine Revenue by Region
  1. 7.1 Global Equine Influenza Vaccine Revenue by Region
  2. 7.1.1 Global Equine Influenza Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Equine Influenza Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Equine Influenza Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Equine Influenza Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Equine Influenza Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Equine Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Equine Influenza Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Equine Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Equine Influenza Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Equine Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Equine Influenza Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Equine Influenza Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Equine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Equine Influenza Vaccine Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Merck Animal Health
  8. 8.2.1 Merck Animal Health Company Information
  9. 8.2.2 Merck Animal Health Business Overview
  10. 8.2.3 Merck Animal Health Equine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Animal Health Equine Influenza Vaccine Product Portfolio
  12. 8.2.5 Merck Animal Health Recent Developments
  13. 8.3 Boehringer Ingelheim Vetmedica
  14. 8.3.1 Boehringer Ingelheim Vetmedica Company Information
  15. 8.3.2 Boehringer Ingelheim Vetmedica Business Overview
  16. 8.3.3 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Product Portfolio
  18. 8.3.5 Boehringer Ingelheim Vetmedica Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Equine Influenza Vaccine Value Chain Analysis
  2. 9.1.1 Equine Influenza Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Equine Influenza Vaccine Production Mode & Process
  6. 9.2 Equine Influenza Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Equine Influenza Vaccine Distributors
  9. 9.2.3 Equine Influenza Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst